---
category: news
title: "Sinaptica’s SinaptiStim – AD Systems Receives Breakthrough Device Status"
excerpt: "The FDA has granted Sinaptica Therapeutics a Breakthrough Device designation for its SinaptiStim – AD System, an electromagnetic therapy for cognitive and functional decline in Alzheimer’s disease patients."
publishedDateTime: 2022-10-20T21:36:00Z
originalUrl: "https://www.fdanews.com/articles/209882-sinapticas-sinaptistim-ad-systems-receives-breakthrough-device-status"
webUrl: "https://www.fdanews.com/articles/209882-sinapticas-sinaptistim-ad-systems-receives-breakthrough-device-status"
type: article
quality: 3
heat: 3
published: false

provider:
  name: FDAnews
  domain: fdanews.com

topics:
  - AI in Healthcare
  - AI

secured: "5obiUKNgFFlwk6EUIhjw0yc3v6K3M6eBi8zFdi84V1/PZFrTWG0d43uYdvE5lFp4QYDoIkNUfCEO4xo1HBXBlBGw4+GSeKZthfijGtKi1R9xdGhk4wpBNQQj9zBATrGs8cV3XLU8fmougkGPa9F9f/97K+wH0Osd9DY0jiNqrbPVzYXtvrRaeiBlEPZbqlk9riqXKxIHocdMHc6egExD0Yq9I4QYVmpw8NU1KZisU285bu9vHZWNx8wZk0Y8rH8NcPDc55ldntxa9rOCcRHPkKHwjoWuLxq2X+XxgGiw2tY8kL6krLsApJniXoJdznai+AYu6v0LDoXzflj7YQn1HThhYeiUrap1n6tQ/KYeDps=;cT4kveyZgA1smSTyj87YHA=="
---

